The Future of Ph+ ALL Treatments

Medical doctors discuss the future of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and their five-year outlook for advancements and potential cures for the disease.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Jamesk Mccloskey ,Jonathan Abbas ,Ryan Haumschild ,Vivian Tambe Ebot ,Elias Jabbour ,Peer Exchange ,Vivian Tambe Ebot Tar ,Transplant ,Chemotherapy ,Nmrd ,Minimal Residual Disease ,Remission ,Mitki ,Tyrosine Kinase Inhibitor ,Standard Of Care ,Dasatinib ,Immunotherapy ,